CELLULAR BIOMEDICINE GROUP
Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.
CELLULAR BIOMEDICINE GROUP
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2009-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.cellbiomedgroup.com
Total Employee:
101+
Status:
Active
Contact:
+1 650-566-5064
Email Addresses:
[email protected]
Total Funding:
203.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Microsoft Azure DNS Facebook Sharer Twitter Tweet Button Alibaba
Similar Organizations
Accessbio
Access BIO is a consulting group focused on the development of drug, biologic, and medical device products.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Monarch Mining
Monarch Mining is a fully integrated mining company that owns four advanced projects.
Proov
Proov offers the most advanced system for women to evaluate their hormones at home, built upon patented, FDA cleared medical devices.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-08-06 | Agreen Biotech | Agreen Biotech acquired by Cellular Biomedicine Group | 22 M USD |
Investors List
TF Capital
TF Capital investment in Series A - Cellular Biomedicine Group
YF Capital
YF Capital investment in Series A - Cellular Biomedicine Group
Sequoia Capital China
Sequoia Capital China investment in Series A - Cellular Biomedicine Group
GIC
GIC investment in Series A - Cellular Biomedicine Group
AstraZeneca
AstraZeneca investment in Series A - Cellular Biomedicine Group
Sailing Capital
Sailing Capital investment in Post-IPO Equity - Cellular Biomedicine Group
Wuhan Dangdai Science & Technology Industries Group
Wuhan Dangdai Science & Technology Industries Group investment in Post-IPO Equity - Cellular Biomedicine Group
Official Site Inspections
http://www.cellbiomedgroup.com
- Host name: 203.107.60.192
- IP address: 203.107.60.192
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Cellular Biomedicine Group"
Cellular Biomedicine Group - Crunchbase Company โฆ
Contact Email [email protected] Phone Number +1 650-566-5064 Cellular Biomedicine Group is a biomedicine firm engaged in the development โฆSee details»
Celllular Biomedicine Group - LinkedIn
Celllular Biomedicine Group | 500 followers on LinkedIn. Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases.See details»
Cellular Biomedicine Group - Overview, News & Similar
Explore Complete Organization Structure. Is Cellular Biomedicine Group your ideal customer? Let us give you the heads up on whether it's a good time to reach out ... (301) 825-5320 Website: โฆSee details»
Cellular Biomedicine Group - businessabc
Feb 25, 2025 cellbiomedgroup.com Dive deeper into fresh insights across Business , Industry Leaders and Influencers , Organizations , Education , and Investors for a comprehensive view. โฆSee details»
Cellular Biomedicine Group - 2025 Company Profile - Tracxn
Feb 26, 2025 Cellular Biomedicine is developing cellular therapeutics for cancer, orthopaedic disorders, and COPD. Its stem cell drug pipeline includes AlloJoin, an off-the-shelf allogeneic โฆSee details»
CBMG Holdings Overview | SignalHire Company Profile
Organization Website: cellbiomedgroup.com : Phone Number +1 (240)552-5870: CBMG Holdings industries Biotech: Headquarters Location: 9605 Medical Center Dr, Rockville, Maryland, โฆSee details»
Cellular Biomedicine Group - Datanyze
Www.cellbiomedgroup.com Cellular Biomedicine Group Profile and History Cellular Biomedicine Group Inc., a biopharmaceutical company, develops treatments for cancerous and โฆSee details»
Cellular Biomedicine Group Company Profile -Sales, Contacts ...
Www.cellbiomedgroup.com: There are 439 Companies located at 1345 AVENUE OF THE AMERICAS, New York, NY 10105 Map View larger ... This organization primarily operates in โฆSee details»
Organization: Cellular Biomedicine Group LEI โฆ
Cellular Biomedicine Group. Information about the issuer. News and credit ratings. (LEI 529900K2GY1VG3RDS666). Tables with accounting and financial reporting.See details»
Celllular Biomedicine Group - SignalHire
Organization Website: cellbiomedgroup.com : Social Links: Phone Number: 1-347-905-5663: Celllular Biomedicin... industries Biotech, Biotechnology: Headquarters Location: ๅผ ๆฑๆณๆ็ฌฌ โฆSee details»
Cellular Biomedicine Group (Shanghai) Ltd. - synapse.zhihuiya.com
Adipose-derived mesenchymal stem cells (ADMSCs) possess immunomodulation property, yet their therapeutic potential in asthma is unclear. This study aimed to explore the effects of โฆSee details»
Cellular Biomedicine Group Announces Exclusive Collaboration โฆ
ROCKVILLE, Md., May 2, 2023 /PRNewswire/ -- Cellular Biomedicine Group Inc. (CBMG or the Company), a clinical-stage biopharmaceutical company focused on discovery and โฆSee details»
Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger ...
Aug 12, 2020 Copies of the documents filed with the SEC by CBMG will also be available free of charge on CBMG's website at https://www.cellbiomedgroup.com or by directing a request to โฆSee details»
Cellular Biomedicine Group, Inc. Announces Completion of Merger
Feb 19, 2021 ROCKVILLE, Md. and SHANGHAI, Feb. 19, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the โฆSee details»
Cellular Biomedicine draws a line under its past
Dec 2023: J&J deal extended to China: Relates to C-CAR039 & C-CAR066, terms undisclosed: Dec 2023: Co-development deal with AstraZeneca: Cross-licensing deal relating to C-CAR031 โฆSee details»
Cellular Biomedicine Group (CBMG) to Host Investor R&D
Jun 30, 2020 To learn more about CBMG, please visit www.cellbiomedgroup.com. Forward-Looking Statements Statements in this press release relating to plans, strategies, trends, โฆSee details»
Cellular Biomedicine Group, Inc. Announces Completion of Merger
Feb 19, 2021 ROCKVILLE, Md. and SHANGHAI, Feb. 19, 2021/ PRNewswire/-- Cellular Biomedicine Group, Inc. today announced the completion of the merger of the Company with โฆSee details»
Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and โฆ
Jul 13, 2020 To learn more about CBMG, please visit www.cellbiomedgroup.com. Forward-Looking Statements Statements in this press release relating to plans, strategies, specific โฆSee details»
Cellular Biomedicine Group's ReJoin® Therapy Receives Stem
Sep 28, 2019 Company Contact: Derrick C. Li Head of Strategy and Investor Relations, CBMGPhone: 917-717-0994 Email: [email protected]. Investor Contact: ...See details»
Inside the futuristic biotech startup Cellares thatโs building a cure ...
2 days ago Inside the futuristic biotech startup Cellares thatโs building a cure for cancer with $355 million in fundingSee details»